Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
VSee Health ( (VSEE) ) has issued an update.
On December 4, 2025, VSee Health, Inc. filed a Certificate of Designation for its Series B Convertible Preferred Stock, effective December 5, 2025. This move outlines the preferences, rights, and limitations of the Series B stock, which ranks senior to common stock and junior securities, on parity with Series A preferred stock, and junior to any future senior securities. The Series B stock is convertible to common stock under certain conditions and carries specific dividend rights, impacting the company’s capital structure and potentially influencing shareholder value.
The most recent analyst rating on (VSEE) stock is a Hold with a $0.54 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.
Spark’s Take on VSEE Stock
According to Spark, TipRanks’ AI Analyst, VSEE is a Neutral.
VSee Health’s overall stock score is primarily impacted by its weak financial performance and concerning valuation metrics. Technical analysis indicates bearish momentum, further weighing on the score. The recent corporate event provides some positive outlook but is insufficient to offset the broader challenges.
To see Spark’s full report on VSEE stock, click here.
More about VSee Health
VSee Health, Inc. operates in the healthcare industry, focusing on providing innovative health solutions. The company is involved in the issuance of capital stock, including preferred and common stock, to support its financial and operational strategies.
Average Trading Volume: 13,505,928
Technical Sentiment Signal: Sell
Current Market Cap: $17.64M
For an in-depth examination of VSEE stock, go to TipRanks’ Overview page.